Skip to main content
. Author manuscript; available in PMC: 2022 Jan 28.
Published in final edited form as: IEEE Trans Neural Syst Rehabil Eng. 2021 Jan 28;28(12):3129–3139. doi: 10.1109/TNSRE.2020.3031495

TABLE V.

Significant fNIRS RSFC changes in ALS Patients Compared to the Healthy Control Group

fIVIRS Connection Healthy Average RSFC±STD ALS Average RSFC±STD p-value
CH2-CH4 0.56±0.09 0.8110.10 0.02
CH13-CH4 0.56±0.09 0.81±0.1 0.02
CH13-CH7 0.61±0.08 0.73±0.05 0.03
CH6-CH7 0.74±0.05 0.89±0.07 0.04
CH6-CH10 0.61±0.07 0.79±0.09 0.02
CH6-CH13 0.47±0.06 0.79±0.07 0.01
CH11-CH14 0.48±0.08 0.74±0.11 0.02
CH6-CH2 0.71±0.05 0.83±0.06 0.02